Search Results - Yulius Setiady
- Showing 1 - 1 results of 1
-
1
A CD123-targeting antibody-drug conjugate, IMGN632, designed to eradicate AML while sparing normal bone marrow cells by Yelena Kovtun, Gregory E. Jones, Sharlene Adams, Lauren Harvey, Charlene A. Audette, Alan Wilhelm, Chen Bai, Lingyun Rui, Rassol Laleau, Fenghua Liu, Olga Ab, Yulius Setiady, Nicholas C. Yoder, Victor S. Goldmacher, Ravi V.J. Chari, Jan Pinkas, Thomas Chittenden
Published in Blood Advances (2018-04-01)Get full text
Article
